Granahan Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Granahan Investment Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-19,321	Closed	-$973K	–	201
2018 Q3	$973K	Sell	19,321 -7,068	-27%	-$349K	0.05%	180
2018 Q2	$1.58M	Sell	26,389 -45,600	-63%	-$2.36M	0.1%	172
2018 Q1	$3.3M	Sell	71,989 -74,407	-51%	-$3.11M	0.24%	116
2017 Q4	$5.83M	Buy	146,396 +27,614	+23%	+$1.09M	0.46%	78
2017 Q3	$4.75M	Sell	118,782 -125	-0.1%	-$5.41K	0.4%	92
2017 Q2	$5.13M	Sell	118,907 -72,031	-38%	-$2.56M	0.47%	79
2017 Q1	$5.98M	Sell	190,938 -520,661	-73%	-$14M	0.6%	61
2016 Q4	$18M	Sell	711,599 -95,450	-12%	-$2.13M	0.62%	66
2016 Q3	$20M	Sell	807,049 -53,920	-6%	-$1.22M	0.65%	59
2016 Q2	$17.5M	Buy	860,969 +471,129	+121%	+$8.36M	0.64%	55
2016 Q1	$5.95M	Buy	+389,840	New	+$5.09M	0.22%	144

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Granahan Investment Management's SUPN Position: Q4 2018 in Review

Granahan Investment Management sold out of Supernus Pharmaceuticals (SUPN) in Q4 2018, closing a stake of 19,321 shares — an estimated $973K sold.

Granahan Investment Management first reported a position in SUPN in Q1 2016 and held it in 11 quarters. The position peaked at $20M in Q3 2016. 274 funds tracked by Wall St. Rank hold SUPN as of Q4 2018.

Granahan Investment Management reported no remaining Supernus Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Granahan Investment Management sold 19,321 Supernus Pharmaceuticals shares in Q4 2018, an estimated $973K.
Granahan Investment Management first reported a position in Supernus Pharmaceuticals in Q1 2016 and held it in 11 quarters.
Granahan Investment Management's Supernus Pharmaceuticals position peaked at $20M in Q3 2016.
274 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2018.

Based on Granahan Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.